Improvement in refractory obsessive compulsive disorder with dronabinol.
Schindler
Frank
F
Anghelescu
Ion
I
Regen
Francesca
F
Jockers-Scherubl
Maria
M
D000328:Adult; D002186:Cannabinoids / Q000627:therapeutic use; D015897:Comorbidity; D003865:Major Depressive Disorder / Q000453:epidemiology; D013759:Dronabinol / Q000627:therapeutic use*; D004351:Drug Resistance; D005260:Female; D006801:Humans; D008297:Male; D009771:Obsessive-Compulsive Disorder / Q000188:drug therapy* / Q000453:epidemiology / Q000523:psychology; D011619:Psychotropic Drugs / Q000627:therapeutic use*; D012559:Schizophrenia / Q000453:epidemiology; D016896:Treatment Outcome
D002186:Cannabinoids; D011619:Psychotropic Drugs; D013759:Dronabinol